A detailed history of Eagle Health Investments LP transactions in Natera, Inc. stock. As of the latest transaction made, Eagle Health Investments LP holds 632,714 shares of NTRA stock, worth $67.4 Million. This represents 10.75% of its overall portfolio holdings.

Number of Shares
632,714
Previous 690,862 8.42%
Holding current value
$67.4 Million
Previous $43.3 Million 33.72%
% of portfolio
10.75%
Previous 8.79%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

SELL
$59.21 - $92.9 $3.44 Million - $5.4 Million
-58,148 Reduced 8.42%
632,714 $57.9 Million
Q4 2023

Feb 12, 2024

BUY
$37.55 - $62.64 $3.57 Million - $5.96 Million
95,168 Added 15.98%
690,862 $43.3 Million
Q2 2023

Aug 14, 2023

SELL
$47.08 - $55.16 $8.91 Million - $10.4 Million
-189,200 Reduced 24.11%
595,694 $29 Million
Q1 2023

May 12, 2023

SELL
$36.57 - $58.29 $1.1 Million - $1.75 Million
-30,100 Reduced 3.69%
784,894 $43.6 Million
Q4 2022

Feb 13, 2023

BUY
$34.17 - $47.91 $7.48 Million - $10.5 Million
219,000 Added 36.75%
814,994 $32.7 Million
Q3 2022

Nov 14, 2022

BUY
$36.93 - $56.68 $923,250 - $1.42 Million
25,000 Added 4.38%
595,994 $26.1 Million
Q2 2022

Aug 11, 2022

BUY
$28.13 - $44.54 $3.47 Million - $5.5 Million
123,500 Added 27.6%
570,994 $20.2 Million
Q1 2022

May 12, 2022

BUY
$30.32 - $91.33 $7.15 Million - $21.5 Million
235,800 Added 111.39%
447,494 $18.2 Million
Q4 2021

Feb 10, 2022

BUY
$86.26 - $119.0 $4.07 Million - $5.62 Million
47,200 Added 28.69%
211,694 $19.8 Million
Q3 2021

Oct 20, 2021

BUY
$100.17 - $126.36 $130,221 - $164,268
1,300 Added 0.8%
164,494 $18.3 Million
Q2 2021

Jul 19, 2021

SELL
$86.05 - $119.72 $447,460 - $622,544
-5,200 Reduced 3.09%
163,194 $18.5 Million
Q1 2021

Apr 23, 2021

BUY
$91.47 - $124.36 $8.21 Million - $11.2 Million
89,794 Added 114.24%
168,394 $17.1 Million
Q4 2020

Feb 04, 2021

BUY
$66.66 - $111.74 $5.24 Million - $8.78 Million
78,600 New
78,600 $7.82 Million

Others Institutions Holding NTRA

About Natera, Inc.


  • Ticker NTRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 96,957,400
  • Market Cap $10.3B
  • Description
  • Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...
More about NTRA
Track This Portfolio

Track Eagle Health Investments LP Portfolio

Follow Eagle Health Investments LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eagle Health Investments LP, based on Form 13F filings with the SEC.

News

Stay updated on Eagle Health Investments LP with notifications on news.